Literature DB >> 15532038

Characterization of the metabolic burden on Escherichia coli DH1 cells imposed by the presence of a plasmid containing a gene therapy sequence.

A Rozkov1, C A Avignone-Rossa, P F Ertl, P Jones, R D O'Kennedy, J J Smith, J W Dale, M E Bushell.   

Abstract

The presence of a plasmid, containing gene sequences for DNA immunotherapy that are not expressed in microbial culture, imposed a degradation in bioreactor performance in cultures of the host E. coli strain. Significant decreases in growth rate (24%) and biomass yield (7%) and a corresponding increase in overflow metabolism were observed in a strain containing a therapeutic sequence (a hepatitis B antigen under the control of a CMV promotor). The observed increase in overflow metabolism was incorporated into a Metabolic Flux Analysis (MFA) model (as acetate secretion). Metabolic flux analysis revealed an increase in TCA cycle flux, consistent with an increased respiration rate observed in plasmid-containing cells. These effects are thought to result from increased ATP synthesis requirements (24%) arising from the expression of the Kanr plasmid marker gene whose product accounted for 18% of the cell protein of the plasmid-containing strain. These factors will necessitate significantly higher aeration and agitation rates or lower nutrient feed rates in high-density cultures than would be expected for plasmid-free cultures. 2004 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15532038     DOI: 10.1002/bit.20327

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  28 in total

Review 1.  Rational vector design for efficient non-viral gene delivery: challenges facing the use of plasmid DNA.

Authors:  Juergen Mairhofer; Reingard Grabherr
Journal:  Mol Biotechnol       Date:  2008-06       Impact factor: 2.695

Review 2.  New generation of plasmid backbones devoid of antibiotic resistance marker for gene therapy trials.

Authors:  Gaëlle Vandermeulen; Corinne Marie; Daniel Scherman; Véronique Préat
Journal:  Mol Ther       Date:  2011-08-30       Impact factor: 11.454

3.  High-Level Production of Plasmid DNA by Escherichia coli DH5α ΩsacB by Introducing inc Mutations.

Authors:  Ram Narayan Trivedi; Parvez Akhtar; Jonathan Meade; Patrick Bartlow; Mohammad M Ataai; Saleem A Khan; Michael M Domach
Journal:  Appl Environ Microbiol       Date:  2014-09-12       Impact factor: 4.792

4.  Genetic (In)stability of 2,6-Dichlorobenzamide Catabolism in Aminobacter sp. Strain MSH1 Biofilms under Carbon Starvation Conditions.

Authors:  Benjamin Horemans; Bart Raes; Hannelore Brocatus; Jeroen T'Syen; Caroline Rombouts; Lynn Vanhaecke; Johan Hofkens; Dirk Springael
Journal:  Appl Environ Microbiol       Date:  2017-05-17       Impact factor: 4.792

Review 5.  Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production.

Authors:  James A Williams; Aaron E Carnes; Clague P Hodgson
Journal:  Biotechnol Adv       Date:  2009-02-20       Impact factor: 14.227

6.  Comparative analysis of L-sorbose dehydrogenase by docking strategy for 2-keto-L-gulonic acid production in Ketogulonicigenium vulgare and Bacillus endophyticus consortium.

Authors:  Si Chen; Nan Jia; Ming-Zhu Ding; Ying-Jin Yuan
Journal:  J Ind Microbiol Biotechnol       Date:  2016-08-26       Impact factor: 3.346

7.  Generic plasmid DNA production platform incorporating low metabolic burden seed-stock and fed-batch fermentation processes.

Authors:  James A Williams; Jeremy Luke; Sarah Langtry; Sheryl Anderson; Clague P Hodgson; Aaron E Carnes
Journal:  Biotechnol Bioeng       Date:  2009-08-15       Impact factor: 4.530

8.  Engineering Escherichia coli to increase plasmid DNA production in high cell-density cultivations in batch mode.

Authors:  Gheorghe M Borja; Eugenio Meza Mora; Blanca Barrón; Guillermo Gosset; Octavio T Ramírez; Alvaro R Lara
Journal:  Microb Cell Fact       Date:  2012-09-19       Impact factor: 5.328

9.  Factors affecting plasmid production in Escherichia coli from a resource allocation standpoint.

Authors:  Drew S Cunningham; Richard R Koepsel; Mohammad M Ataai; Michael M Domach
Journal:  Microb Cell Fact       Date:  2009-05-22       Impact factor: 5.328

10.  Construction of Escherichia coli strains with chromosomally integrated expression cassettes for the synthesis of 2'-fucosyllactose.

Authors:  Florian Baumgärtner; Lyudmila Seitz; Georg A Sprenger; Christoph Albermann
Journal:  Microb Cell Fact       Date:  2013-05-01       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.